TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20605091

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (ascorbic acid 120 mg, vitamin E 30 mg, β-carotene 6 mg, selenium 100 μg, zinc 20 mg)
Number of subjects: 12741

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12741

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 12741
Study: 18823440

Group type: EXPERIMENTAL
Intervention: Granulocytapheresis (GCAP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 80
Study: 16651490

Group type: EXPERIMENTAL
Intervention: Test characteristics (TC)
Number of subjects: 1502

Group type: EXPERIMENTAL
Intervention: Test characteristics defined (TC defined)
Number of subjects: 1502

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1502
Study: 12823330

Group type: EXPERIMENTAL
Intervention: ADHD children
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Non-clinical hyperactive children
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ADHD children with comorbid ODD
Number of subjects: 64
Study: 10815156

Group type: EXPERIMENTAL
Intervention: Cryotherapy for Retinopathy of Prematurity (CRYO‐ROP)
Number of subjects: 766
Study: 9403646

Group type: EXPERIMENTAL
Intervention: Ibuprofen (10.3 ± 1.9 mg/kg)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Paracetamol (9.8 ± 1.9 mg/kg)
Number of subjects: 116
Study: 8130296

Group type: EXPERIMENTAL
Intervention: Thermal biofeedback (TBF) - 16 sessions of hand and foot warming
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Frontal EMG biofeedback - 16 sessions
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular home monitoring of BP
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: All conditions combined
Number of subjects: 33
Study: 3654237

Group type: EXPERIMENTAL
Intervention: Structured educational program
Number of subjects: 26

Group type: COMPARATOR
Intervention: No structured educational interventions (Control)
Number of subjects: 26
Study: 28868810

Group type: EXPERIMENTAL
Intervention: Genous endothelial progenitor cell capturing stent (ECS)
Number of subjects: 193

Group type: COMPARATOR
Intervention: TAXUS Liberté paclitaxel‐eluting stent (PES)
Number of subjects: 193
Study: 28028649

Group type: EXPERIMENTAL
Intervention: Modified extradiaphragmatic thoracolumbar approach
Number of subjects: 106

Group type: COMPARATOR
Intervention: Traditional transdiaphragmatic thoracolumbar approach
Number of subjects: 106
Study: 24337670

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (BGL elevated to 16.7 ± 0.9 mmol L(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (BGL maintained at 5.5 ± 0.1 mmol L(‐1))
Number of subjects: 12
Study: 24279294

Group type: EXPERIMENTAL
Intervention: 10-week dog-based physical activity intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 20675882

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other drugs and newly developed drugs
Number of subjects: 0
Study: 19030637

Group type: EXPERIMENTAL
Intervention: Oral glucose
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: EMLA
Number of subjects: 76
Study: 16098704

Group type: EXPERIMENTAL
Intervention: GALM program (15 sessions of 60 min each, once a week)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: GALM program
Number of subjects: 181
Study: 14511968

Group type: EXPERIMENTAL
Intervention: Structured one‐to‐one in‐hospital education session
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual verbal encouragement (Control)
Number of subjects: 106
Study: 10803620

Group type: EXPERIMENTAL
Intervention: Innervated flaps
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-innervated flaps
Number of subjects: 12
Study: 8849259

Group type: EXPERIMENTAL
Intervention: Ofx2 (2 days of oral ofloxacin treatment at 15 mg/kg/day)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ofx3 (3 days of oral ofloxacin treatment at 15 mg/kg/day)
Number of subjects: 108
Study: 7950227

Group type: EXPERIMENTAL
Intervention: Baluodan (BLD)
Number of subjects: 210
Study: 3627086

Group type: EXPERIMENTAL
Intervention: 100 ppm CO exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 0
Study: 29648854

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study: 26576819

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 198

Group type: COMPARATOR
Intervention: Hatha yoga
Number of subjects: 198

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 198
Study: 24107607

Group type: EXPERIMENTAL
Intervention: Two-vegetable choice (carrots and beans)
Number of subjects: 100

Group type: COMPARATOR
Intervention: One-vegetable choice (carrots)
Number of subjects: 100

Group type: COMPARATOR
Intervention: One-vegetable choice (beans)
Number of subjects: 100
Study: 22909369

Group type: EXPERIMENTAL
Intervention: Narrowband UVB (NBUVB)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Oral PUVA
Number of subjects: 56
Study: 20232583

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (ALA) plus 532 nm KTP laser
Number of subjects: 8

Group type: COMPARATOR
Intervention: 532 nm KTP laser alone
Number of subjects: 8
Study: 18219455

Group type: EXPERIMENTAL
Intervention: Shenyi Capsule
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combined therapy (Shenyi Capsule plus chemotherapy)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 133
Study: 15681495

Group type: EXPERIMENTAL
Intervention: Fluticasone (250 mug/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12952502

Group type: EXPERIMENTAL
Intervention: Frozen FluMist™
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Liquid FluMist™
Number of subjects: 1300
Study: 10994218

Group type: EXPERIMENTAL
Intervention: Home-based care by nurses
Number of subjects: 0
Study: 8856254

Group type: EXPERIMENTAL
Intervention: Regenerated cellulose membranes (RC group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polysulfone membranes (PS group)
Number of subjects: 0
Study: 1826008

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration (12 IU sc at 2000 h for 14 days)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6640551

Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 500 mg/m2/day by iv push X 5 (F)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 400 mg/m2/day iv X 5 plus TZT at a dose of 175 mg/m2/day iv X 3 (FT)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: 5‐FU at a dose of 400 mg/m2/day plus ICRF‐159 at a dose of 600 mg/m2/day orally X 3 (FI)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: MeCCNU at a dose of 150 mg/m2/day orally plus TZT at a dose of 200 mg/m2/day iv X 3 (MT)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: MeCCNU at a dose of 150 mg/m2 orally plus ICRF‐159 at a dose of 500 mg/m2/day orally X 3 (MI)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: ICRF‐159 at a dose of 425 mg/m2/day orally X 3 plus TZT at a dose of 125 mg/m2/day iv X 3 (IT)
Number of subjects: 167

Group type: COMPARATOR
Intervention: 5‐FU alone (Control)
Number of subjects: 167
Study: 31667735

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate tablet (single oral dose, 110 mg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate tablet (single oral dose, 110 mg) with rabeprazole pretreatment (20 mg once daily for 5 days)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Dabigatran etexilate capsule (single oral dose, 110 mg)
Number of subjects: 196
Study: 31034525

Group type: EXPERIMENTAL
Intervention: Balanced gelatine/electrolyte solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-balanced gelatine/electrolyte solution
Number of subjects: 40
Study: 30176970

Group type: EXPERIMENTAL
Intervention: Home sleep apnea testing (HSAT)
Number of subjects: 265
Study: 27619049

Group type: EXPERIMENTAL
Intervention: Short-shaft tympanostomy ventilation tubes
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Long-shaft tympanostomy ventilation tubes
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Fluoroplastic tympanostomy ventilation tubes
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Silicone tympanostomy ventilation tubes
Number of subjects: 400
Study: 24955495

Group type: EXPERIMENTAL
Intervention: High energy beverage preload
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: High energy solid food preload
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Low energy beverage preload
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Low energy solid food preload
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Learning intervention
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Personality and eating behavior questionnaires
Number of subjects: 107
Study: 22424116

Group type: EXPERIMENTAL
Intervention: Bottle A (n = 29)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Bottle B (n = 25)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Bottle A
Number of subjects: 63

Group type: COMPARATOR
Intervention: Bottle B
Number of subjects: 63

Group type: COMPARATOR
Intervention: Breast-fed reference group
Number of subjects: 63
Study: 18207457

Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC) IL-10
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Exhaled breath condensate (EBC) IL-6
Number of subjects: 90

Group type: COMPARATOR
Intervention: Smoker control group
Number of subjects: 90
Study: 17192292

Group type: EXPERIMENTAL
Intervention: Letrozole and FSH
Number of subjects: 523

Group type: COMPARATOR
Intervention: FSH only
Number of subjects: 523
Study: 15167461

Group type: EXPERIMENTAL
Intervention: CollaCote‐epinephrine
Number of subjects: 48

Group type: COMPARATOR
Intervention: CollaCote‐saline
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (CollaCote‐saline)
Number of subjects: 48
Study: 11838001

Group type: EXPERIMENTAL
Intervention: RCT‐Ds
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: RCT‐Ms
Number of subjects: 200

Group type: COMPARATOR
Intervention: RCT‐Ds and RCT‐Ms
Number of subjects: 200
Study: 9616507

Group type: EXPERIMENTAL
Intervention: Turbuhaler (50 micrograms dose -1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: pMDI (100 micrograms dose -1) with spacer (Volumatic)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 86

Group type: COMPARATOR
Intervention: pMDI
Number of subjects: 86
Study: 8018402

Group type: EXPERIMENTAL
Intervention: haemoglobin level (B‐Hb)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: disease‐free interval
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Karnofsky performance status (KPS)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: number of symptoms
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: primary tumour removal
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: S‐aspartate aminotransferase (S‐ASAT)
Number of subjects: 198
Study: 2672900

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 895434

Group type: EXPERIMENTAL
Intervention: Ephedrine (24 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 21
Study: 31190492

Group type: EXPERIMENTAL
Intervention: Auricular point pressing
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Combination of auricular point pressing and EA
Number of subjects: 93
Study: 27749094

Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 974

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 974
Study: 26690033

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia training group (IHTG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study: 23622562

Group type: EXPERIMENTAL
Intervention: Deep anterior lamellar keratoplasty (DALK)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 54
Study: 20693248

Group type: EXPERIMENTAL
Intervention: Dornase alfa
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18273622

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of ranibizumab (3 injections)
Number of subjects: 29
Study: 16828478

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs) for 21 days
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH-a) for 14 days
Number of subjects: 85

Group type: COMPARATOR
Intervention: Basal state
Number of subjects: 85
Study: 12724464

Group type: EXPERIMENTAL
Intervention: Methamphetamine dependence
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 27
Study: 11106130

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.6, 1.2, 1.8, 2.4, and 3.0 microg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fentanyl (0.4, 0.8, 1.3, 2.0, 3.0, and 4.5 microg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9082867

Group type: EXPERIMENTAL
Intervention: Single-dose spinal anaesthesia (n = 150)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Continuous spinal anaesthesia (CSA) (n = 150)
Number of subjects: 300
Study: 7831427

Group type: EXPERIMENTAL
Intervention: Nicotine abstinence for 12 hours
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal smoking for 12 hours (Control)
Number of subjects: 20
Study: 3090127

Group type: COMPARATOR
Intervention: Balloon reservoir volume of 3 l
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 6 l
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 12 l
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 18 l
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Balloon reservoir volume of 24 l
Number of subjects: 20
Study: 30240526

Group type: EXPERIMENTAL
Intervention: rTMS (10 high frequency sessions over the left dorsolateral prefrontal cortex)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 39
Study: 26684635

Group type: EXPERIMENTAL
Intervention: Methylsulfonylmethane (5 g) and Boswellic acids (7.2 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Glucosamine sulfate (1500 mg)
Number of subjects: 120
Study: 24457893

Group type: EXPERIMENTAL
Intervention: Resin-based composite restorations
Number of subjects: 534

Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Preventative resin restorations
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Dental sealants (polyacid-modified compomer, flowable composite)
Number of subjects: 534
Study: 22147460

Group type: EXPERIMENTAL
Intervention: Vedolizumab (2, 6, or 10 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 20121768

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate/formoterol fixed combination (BDP/FF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate + formoterol delivered as separate inhalers (BDP + FF)
Number of subjects: 0
Study: 18515507

Group type: EXPERIMENTAL
Intervention: Antibiotics (cefotetan or cefoxitin)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 15937676

Group type: COMPARATOR
Intervention: Video group (one-time oral instruction by a physiotherapist and issued a video for home exercise)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Café group (video regimen with three café meetings with other fusion-operated patients)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Training group (exercise therapy; physiotherapist-guided; two times a week for 8 weeks)
Number of subjects: 90
Study: 14654501

Group type: EXPERIMENTAL
Intervention: Health Promoting Schools (HPS) program
Number of subjects: 1852

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1852
Study: 10816228

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerin
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control ointment (polysporin)
Number of subjects: 173
Study: 8871001

Group type: EXPERIMENTAL
Intervention: Synchronous chemotherapy with the 3M regimen (mitoxantrone, methotrexate and Mitomycin‐C) during radiotherapy (CRT)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Synchronous chemotherapy with the 3M regimen (CRT)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Radiotherapy alone (RTO)
Number of subjects: 197
Study: 1728624

Group type: EXPERIMENTAL
Intervention: Predetermined meal three times daily (including cottage cheese, apple sauce, vanilla ice cream, and other selected foods)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group selected their own meal
Number of subjects: 19
Study: 6426289

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (2.1 mg/hour intravenously for 48 hours)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no specific therapy)
Number of subjects: 21
Study: 29343510

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 0
Study: 27552545

Group type: EXPERIMENTAL
Intervention: GH (0.67 mg/m2 · d)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 24396050

Group type: EXPERIMENTAL
Intervention: Arm A: smart phone with applications to guide interview, report data, show motivational video, and offer appointment for women with an abnormal CBE.
Number of subjects: 22337

Group type: EXPERIMENTAL
Intervention: Arm B: smart phone/applications identical to Arm A plus CHW had training in 'patient navigation'.
Number of subjects: 22337

Group type: COMPARATOR
Intervention: Control Arm C: no smart phone; same interview recorded on paper.
Number of subjects: 22337
Study: 22179300

Group type: EXPERIMENTAL
Intervention: Simulation training group (1 hour training session on needling and proper hand‐eye coordination)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional training group (4 didactic lectures on PNBs with ultrasound guidance)
Number of subjects: 20
Study: 20647170

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (155 U-195 U)
Number of subjects: 679

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 679
Study: 18586812

Group type: EXPERIMENTAL
Intervention: Resistance-based, reciprocal affected leg locomotor training protocol using the NuStep apparatus
Number of subjects: 7

Group type: COMPARATOR
Intervention: Home exercise programme (HEP) consisting of self-supervised practice with fractionated joint movements of the lower limb
Number of subjects: 7
Study: 16222518

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Insulin-induced antilipolysis and lipogenesis
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control women
Number of subjects: 25
Study: 12020484

Group type: EXPERIMENTAL
Intervention: Transmyocardial revascularization with CO(2) laser (TMR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Continued medical treatment
Number of subjects: 100
Study: 10468684

Group type: EXPERIMENTAL
Intervention: RBC 400 mg, amoxycillin 1 g, clarithromycin 500 mg (RAC)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: RBC 400 mg, metronidazole 400 mg, clarithromycin 500 mg (RMC)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: RBC 400 mg, metronidazole 400 mg, tetracycline 1 g (RMT)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: RBC 400 mg plus clarithromycin 500 mg for 2 weeks (RC-2)
Number of subjects: 398
Study: 8522636

Group type: EXPERIMENTAL
Intervention: Moexipril (7.5 mg and 15 mg once daily)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Verapamil (180 mg and 240 mg once daily)
Number of subjects: 178
Study: 1964898

Group type: EXPERIMENTAL
Intervention: Canned baked beans (6 cans of 440 g per week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Canned spaghetti (control)
Number of subjects: 20
Study: 7457945

Group type: EXPERIMENTAL
Intervention: Fentanyl citrate administered intramuscularly at 0.006 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine chlorhydrate administered at 0.150 mg/kg
Number of subjects: 0
Study: 31677033

Group type: EXPERIMENTAL
Intervention: d3RP‐NF2 program (8 week mind‐body resiliency program)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d3RP‐NF2 program
Number of subjects: 0

Group type: COMPARATOR
Intervention: dHEP‐NF2 (health education control)
Number of subjects: 0
Study: 27655223

Group type: EXPERIMENTAL
Intervention: WBRT plus 50 mg veliparib BID (n=103)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: WBRT plus 200 mg veliparib BID (n=102)
Number of subjects: 307

Group type: COMPARATOR
Intervention: WBRT plus placebo BID (n=102)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 307
Study: 25872665

Group type: EXPERIMENTAL
Intervention: Jingui external lotion
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 168
Study: 24064726

Group type: EXPERIMENTAL
Intervention: Bread and butter with boiled spinach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bread and butter meal
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bread meal
Number of subjects: 24
Study: 22108480

Group type: EXPERIMENTAL
Intervention: Antithromboembolic stockings, worn 24h/day
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no stockings)
Number of subjects: 201
Study: 19778662

Group type: EXPERIMENTAL
Intervention: Statin therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher levels of inflammatory biomarkers (e.g., CRP, interleukin-6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher levels of CRP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inflammatory biomarkers
Number of subjects: 0